Suppr超能文献

退伍军人事务部糖尿病试验(VADT)17年后的眼部结局

Eye Outcomes in Veteran Affairs Diabetes Trial (VADT) After 17 Years.

作者信息

Azad Nasrin, Agrawal Lily, Bahn Gideon, Emanuele Nicholas V, Reaven Peter D, Hayward Rodney, Reda Domenic

机构信息

Endocrinology Section, Edward Hines, Jr. VA Hospital, Hines, IL

Cooperative Studies Program Coordinating Center, Hines, IL.

出版信息

Diabetes Care. 2021 Jun 29;44(10):2397-402. doi: 10.2337/dc20-2882.

Abstract

OBJECTIVE

The objective of this study was to assess the long-term role of intensive glycemic control (INT) compared with standard glycemic control in accumulated eye procedures in patients with advanced diabetes.

RESEARCH DESIGN AND METHODS

We compared the effect of treatment assignment on the accumulated number of eye procedures during the intervention period of the Veteran Affairs Diabetes Trial (VADT) (2000-2008) (median follow-up 5.6 years), the interim VADT follow-up study (2000-2013), and the full 17 years of VADT follow-up (2000-2017). We further analyzed data using various cardiovascular markers in two models. Model I included total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, systolic and diastolic blood pressure, and BMI. Model II included these covariates plus age and diabetic retinopathy (DR) severity score at baseline of the original trial.

RESULTS

The final analysis of the data showed a mild but nonsignificant increase in number of procedures and in retinal or retinal plus cataract surgery during the three periods of the study.

CONCLUSIONS

We found no significant benefit of INT during the original trial period in eye-related procedures, such as various procedures for DR, or during the 17 years of follow-up in cataract surgery. However, after adjusting data for some known vascular markers, the increase in the number of eye procedures with INT becomes more prevalent. This finding indicates that INT might not have a protective role in events requiring surgery in individuals with advanced diabetes.

摘要

目的

本研究的目的是评估强化血糖控制(INT)与标准血糖控制相比,在晚期糖尿病患者累积眼部手术中的长期作用。

研究设计与方法

我们比较了治疗分配对退伍军人事务部糖尿病试验(VADT)(2000 - 2008年)(中位随访5.6年)、VADT中期随访研究(2000 - 2013年)以及VADT完整17年随访(2000 - 2017年)期间累积眼部手术数量的影响。我们在两个模型中使用各种心血管标志物进一步分析数据。模型I包括总胆固醇、高密度脂蛋白胆固醇、低密度脂蛋白胆固醇、甘油三酯、收缩压和舒张压以及体重指数。模型II包括这些协变量加上原始试验基线时的年龄和糖尿病视网膜病变(DR)严重程度评分。

结果

数据的最终分析显示,在研究的三个阶段,手术数量以及视网膜或视网膜加白内障手术数量有轻微但不显著的增加。

结论

我们发现在原始试验期间,强化血糖控制在与眼睛相关的手术(如各种糖尿病视网膜病变手术)中没有显著益处,在白内障手术的17年随访中也没有。然而,在对一些已知血管标志物的数据进行调整后,强化血糖控制组眼部手术数量的增加变得更为普遍。这一发现表明,强化血糖控制可能对晚期糖尿病患者需要手术的情况没有保护作用。

相似文献

1
Eye Outcomes in Veteran Affairs Diabetes Trial (VADT) After 17 Years.
Diabetes Care. 2021 Jun 29;44(10):2397-402. doi: 10.2337/dc20-2882.
2
Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT).
Diabetologia. 2018 Feb;61(2):295-299. doi: 10.1007/s00125-017-4473-2. Epub 2017 Nov 3.
3
Association of PAI-1 and fibrinogen with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT).
Diabetes Care. 2014 Feb;37(2):501-6. doi: 10.2337/dc13-1193. Epub 2013 Oct 7.
4
5
Design of the cooperative study on glycemic control and complications in diabetes mellitus type 2: Veterans Affairs Diabetes Trial.
J Diabetes Complications. 2003 Nov-Dec;17(6):314-22. doi: 10.1016/s1056-8727(02)00277-5.
7
Glycaemic separation and risk factor control in the Veterans Affairs Diabetes Trial: an interim report.
Diabetes Obes Metab. 2009 Feb;11(2):150-6. doi: 10.1111/j.1463-1326.2008.00933.x. Epub 2008 Jul 29.
8
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2.
10
Review of the veteran affairs diabetes trial: Lessons learned.
Rev Endocr Metab Disord. 2020 Dec;21(4):537-546. doi: 10.1007/s11154-020-09558-5.

引用本文的文献

1
Metabolic memory and diabetic retinopathy: Legacy of glycemia and possible steps into future.
Indian J Ophthalmol. 2024 Jun 1;72(6):796-808. doi: 10.4103/IJO.IJO_2563_23. Epub 2024 May 24.
2
Glycemic Control and Retinal Microvascular Changes in Type 2 Diabetes Mellitus Patients without Clinical Retinopathy.
Diabetes Metab J. 2024 Sep;48(5):983-992. doi: 10.4093/dmj.2023.0149. Epub 2024 Mar 13.
3
The evolving therapeutic landscape of diabetic retinopathy.
Expert Opin Biol Ther. 2023 Jul-Dec;23(10):969-985. doi: 10.1080/14712598.2023.2247987. Epub 2023 Aug 14.
4
Impact of Intensive Glycemic Treatment on Diabetes Complications-A Systematic Review.
Pharmaceutics. 2023 Jun 22;15(7):1791. doi: 10.3390/pharmaceutics15071791.

本文引用的文献

3
4
Intensive diabetes therapy and ocular surgery in type 1 diabetes.
N Engl J Med. 2015 Apr 30;372(18):1722-33. doi: 10.1056/NEJMoa1409463.
5
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.
N Engl J Med. 2014 Oct 9;371(15):1392-406. doi: 10.1056/NEJMoa1407963. Epub 2014 Sep 19.
8
Association of PAI-1 and fibrinogen with diabetic retinopathy in the Veterans Affairs Diabetes Trial (VADT).
Diabetes Care. 2014 Feb;37(2):501-6. doi: 10.2337/dc13-1193. Epub 2013 Oct 7.
9
Effects of medical therapies on retinopathy progression in type 2 diabetes.
N Engl J Med. 2010 Jul 15;363(3):233-44. doi: 10.1056/NEJMoa1001288. Epub 2010 Jun 29.
10
Glucose control and vascular complications in veterans with type 2 diabetes.
N Engl J Med. 2009 Jan 8;360(2):129-39. doi: 10.1056/NEJMoa0808431. Epub 2008 Dec 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验